64 related articles for article (PubMed ID: 16006193)
1. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.
Muthumani K; Choo AY; Hwang DS; Dayes NS; Chattergoon M; Mayilvahanan S; Thieu KP; Buckley PT; Emmanuel J; Premkumar A; Weiner DB
Mol Ther; 2005 Nov; 12(5):910-21. PubMed ID: 16006193
[TBL] [Abstract][Full Text] [Related]
2. T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene.
Yasuda J; Miyao T; Kamata M; Aida Y; Iwakura Y
Virology; 2001 Jul; 285(2):181-92. PubMed ID: 11437653
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.
Muthumani K; Choo AY; Premkumar A; Hwang DS; Thieu KP; Desai BM; Weiner DB
Cell Death Differ; 2005 Aug; 12 Suppl 1():962-70. PubMed ID: 15832179
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function.
Venkatachari NJ; Majumder B; Ayyavoo V
Virology; 2007 Feb; 358(2):347-56. PubMed ID: 17023015
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.
Fakruddin JM; Laurence J
Arch Virol; 2005 Jan; 150(1):67-78. PubMed ID: 15449141
[TBL] [Abstract][Full Text] [Related]
6. Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R.
Zelivianski S; Liang D; Chen M; Mirkin BL; Zhao RY
Apoptosis; 2006 Mar; 11(3):377-88. PubMed ID: 16520893
[TBL] [Abstract][Full Text] [Related]
7. The HIV-1 accessory gene vpr can inhibit antigen-specific immune function.
Muthumani K; Hwang DS; Dayes NS; Kim JJ; Weiner DB
DNA Cell Biol; 2002 Sep; 21(9):689-95. PubMed ID: 12396612
[TBL] [Abstract][Full Text] [Related]
8. Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.
Janoo A; Morrow PW; Tung HY
J Cell Biochem; 2005 Mar; 94(4):816-25. PubMed ID: 15578586
[TBL] [Abstract][Full Text] [Related]
9. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.
Qiao H; McMillan JR
FEBS Lett; 2007 Feb; 581(3):535-40. PubMed ID: 17254575
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.
Muthumani K; Hwang DS; Choo AY; Mayilvahanan S; Dayes NS; Thieu KP; Weiner DB
Int Immunol; 2005 Feb; 17(2):103-16. PubMed ID: 15611322
[TBL] [Abstract][Full Text] [Related]
11. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
[TBL] [Abstract][Full Text] [Related]
13. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator.
Sabbah EN; Druillennec S; Morellet N; Bouaziz S; Kroemer G; Roques BP
Chem Biol Drug Des; 2006 Feb; 67(2):145-54. PubMed ID: 16492162
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain.
Acharjee S; Noorbakhsh F; Stemkowski PL; Olechowski C; Cohen EA; Ballanyi K; Kerr B; Pardo C; Smith PA; Power C
FASEB J; 2010 Nov; 24(11):4343-53. PubMed ID: 20628092
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of HIV-1 viral protein R-induced apoptosis.
Muthumani K; Choo AY; Hwang DS; Chattergoon MA; Dayes NN; Zhang D; Lee MD; Duvvuri U; Weiner DB
Biochem Biophys Res Commun; 2003 May; 304(3):583-92. PubMed ID: 12729593
[TBL] [Abstract][Full Text] [Related]
17. Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.
Vlahakis SR; Bren GD; Algeciras-Schimnich A; Trushin SA; Schnepple DJ; Badley AD
Clin Pharmacol Ther; 2007 Sep; 82(3):294-9. PubMed ID: 17361127
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
Zhou W; Blackwell TS; Goleniewska K; O'Neal JF; Fitzgerald GA; Lucitt M; Breyer RM; Peebles RS
J Leukoc Biol; 2007 Mar; 81(3):809-17. PubMed ID: 17135575
[TBL] [Abstract][Full Text] [Related]
19. Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells.
Moon HS; Yang JS
Mol Cells; 2006 Feb; 21(1):7-20. PubMed ID: 16511342
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1.
Yedavalli VS; Shih HM; Chiang YP; Lu CY; Chang LY; Chen MY; Chuang CY; Dayton AI; Jeang KT; Huang LM
J Virol; 2005 Nov; 79(21):13735-46. PubMed ID: 16227293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]